Article: Obagi Medical Products Releases 3Q 2009 Earnings.

Obagi Medical Products, Inc. has reported third quarter 2009 net income of $3.0 million, or $0.14 per diluted share, compared with $2.9 million, or $0.13 per diluted share, for the third quarter of 2008.

In a release on November 5, the Company noted that net sales were $24.9 million in the third quarter of 2009, a decline of 4 percent from $26.0 million a year ago. Gross margin was 78.9 percent in the third quarter of 2009, compared with 80.3 percent a year ago. This was due primarily to a newly initiated rebate program tied to the use of NuDerm or Condition & Enhance systems in conjunction with cosmetic procedures, which impacted gross margins by 1 percent, and ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!